| Literature DB >> 32538895 |
O Emre Onat1, M Ece Kars1, Şeref Gül2,3, Kaya Bilguvar4, Yiming Wu5, Ayşe Özhan1, Cihan Aydın2,3, A Nazlı Başak6, M Allegra Trusso7, Arianna Goracci7, Chiara Fallerini8, Alessandra Renieri8,9, Jean-Laurent Casanova10,11,12,13,14, Yuval Itan5,15, Cem E Atbaşoğlu16, Meram C Saka16, İ Halil Kavaklı2, Tayfun Özçelik1,17,18.
Abstract
Attention deficit/hyperactivity disorder (ADHD) is a common and heritable phenotype frequently accompanied by insomnia, anxiety, and depression. Here, using a reverse phenotyping approach, we report heterozygous coding variations in the core circadian clock gene cryptochrome 1 in 15 unrelated multigenerational families with combined ADHD and insomnia. The variants led to functional alterations in the circadian molecular rhythms, providing a mechanistic link to the behavioral symptoms. One variant, CRY1Δ11 c.1657+3A>C, is present in approximately 1% of Europeans, therefore standing out as a diagnostic and therapeutic marker. We showed by exome sequencing in an independent cohort of patients with combined ADHD and insomnia that 8 of 62 patients and 0 of 369 controls carried CRY1Δ11. Also, we identified a variant, CRY1Δ6 c.825+1G>A, that shows reduced affinity for BMAL1/CLOCK and causes an arrhythmic phenotype. Genotype-phenotype correlation analysis revealed that this variant segregated with ADHD and delayed sleep phase disorder (DSPD) in the affected family. Finally, we found in a phenome-wide association study involving 9438 unrelated adult Europeans that CRY1Δ11 was associated with major depressive disorder, insomnia, and anxiety. These results defined a distinctive group of circadian psychiatric phenotypes that we propose to designate as "circiatric" disorders.Entities:
Keywords: Genetic diseases; Genetics; Monogenic diseases; Psychiatric diseases
Year: 2020 PMID: 32538895 PMCID: PMC7324179 DOI: 10.1172/JCI135500
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808